Primary |
Drug Use For Unknown Indication |
29.3% |
Product Used For Unknown Indication |
27.4% |
Breast Cancer |
7.7% |
Premedication |
6.4% |
Medication Dilution |
5.3% |
Chemotherapy |
4.8% |
Prophylaxis Of Nausea And Vomiting |
2.7% |
Colorectal Cancer |
1.9% |
Haemodialysis |
1.8% |
Angioplasty |
1.7% |
Fluid Replacement |
1.5% |
Osteomyelitis |
1.5% |
Rheumatoid Arthritis |
1.4% |
Caesarean Section |
1.1% |
Lower Respiratory Tract Infection |
1.1% |
Plasmapheresis |
1.1% |
Renal Failure Chronic |
0.9% |
Anaesthesia |
0.8% |
Intravenous Catheter Management |
0.8% |
Bacteraemia |
0.7% |
|
Death |
18.4% |
Chills |
13.2% |
Pyrexia |
9.5% |
Rash |
5.8% |
Pain |
5.3% |
Disseminated Intravascular Coagulation |
4.7% |
Feeling Hot |
4.2% |
Flushing |
4.2% |
Neuropathy Peripheral |
4.2% |
Hypersensitivity |
3.2% |
Nausea |
3.2% |
Tremor |
3.2% |
Unresponsive To Stimuli |
3.2% |
Vomiting |
3.2% |
Cardiac Arrest |
2.6% |
Malaise |
2.6% |
Overdose |
2.6% |
Shock |
2.6% |
Adverse Event |
2.1% |
Anaphylactoid Reaction |
2.1% |
|
Secondary |
Product Used For Unknown Indication |
36.7% |
Breast Cancer |
19.3% |
Drug Use For Unknown Indication |
15.6% |
Premedication |
7.0% |
Prophylaxis Of Nausea And Vomiting |
6.0% |
Immunodeficiency |
1.8% |
Chronic Fatigue Syndrome |
1.7% |
Laryngitis |
1.7% |
Lower Respiratory Tract Infection |
1.5% |
Caesarean Section |
1.5% |
Medication Dilution |
1.5% |
Anaesthesia |
1.2% |
Off Label Use |
0.8% |
Colorectal Cancer |
0.7% |
Cystic Fibrosis |
0.7% |
Intravenous Catheter Management |
0.6% |
Osteomyelitis |
0.6% |
Cardiac Operation |
0.4% |
Cardiac Output |
0.4% |
Diabetes Mellitus |
0.4% |
|
Neuropathy Peripheral |
30.6% |
Rash |
20.8% |
Disseminated Intravascular Coagulation |
9.4% |
Syncope |
9.4% |
Tremor |
5.6% |
Pain |
2.8% |
Pathogen Resistance |
2.4% |
Antibiotic Level Above Therapeutic |
2.1% |
Chills |
2.1% |
Acinetobacter Test Positive |
1.7% |
Pyrexia |
1.7% |
Vomiting |
1.7% |
Bacterial Sepsis |
1.4% |
Klebsiella Sepsis |
1.4% |
Malaise |
1.4% |
Medication Error |
1.4% |
Sleep Disorder |
1.4% |
Death |
1.0% |
Inflammation |
1.0% |
Anxiety |
0.7% |
|
Concomitant |
Product Used For Unknown Indication |
57.0% |
Drug Use For Unknown Indication |
36.3% |
Pain |
1.1% |
Thrombosis Prophylaxis |
0.6% |
Haemodialysis |
0.6% |
Dialysis |
0.5% |
Pulmonary Embolism |
0.4% |
Cardiac Ablation |
0.4% |
Coronary Artery Bypass |
0.4% |
Catheterisation Cardiac |
0.4% |
Gastrointestinal Disorder |
0.4% |
Peritoneal Dialysis |
0.3% |
Prophylaxis |
0.3% |
Agitation |
0.3% |
Anticoagulant Therapy |
0.3% |
Pruritus |
0.2% |
Deep Vein Thrombosis |
0.2% |
Intravenous Catheter Management |
0.2% |
Aortic Valve Replacement |
0.2% |
Diabetes Mellitus |
0.2% |
|
Vomiting |
30.7% |
Thrombocytopenia |
7.0% |
Unresponsive To Stimuli |
7.0% |
Vascular Insufficiency |
5.3% |
Respiratory Distress |
4.4% |
Swelling Face |
4.4% |
Urosepsis |
4.4% |
Death |
3.5% |
Headache |
3.5% |
Syncope |
3.5% |
Erythema |
2.6% |
Hypotension |
2.6% |
Pharyngeal Oedema |
2.6% |
Pyrexia |
2.6% |
Respiratory Failure |
2.6% |
Thrombosis |
2.6% |
Thrombosis In Device |
2.6% |
Traumatic Brain Injury |
2.6% |
Vascular Graft Occlusion |
2.6% |
Ventricular Tachycardia |
2.6% |
|